These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30541542)

  • 1. Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study.
    Young A; Cotton S; Cruickshank ME
    BMC Womens Health; 2018 Dec; 18(1):200. PubMed ID: 30541542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
    Munro A; Gillespie C; Cotton S; Busby-Earle C; Kavanagh K; Cuschieri K; Cubie H; Robertson C; Smart L; Pollock K; Moore C; Palmer T; Cruickshank ME
    BJOG; 2017 Aug; 124(9):1394-1401. PubMed ID: 28102931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.
    O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
    BJOG; 2014 Oct; 121(11):1421-9. PubMed ID: 24690225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information and cervical screening: a qualitative study of women's awareness, understanding and information needs about HPV.
    Goldsmith MR; Bankhead CR; Kehoe ST; Marsh G; Austoker J
    J Med Screen; 2007; 14(1):29-33. PubMed ID: 17362569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study.
    Cruickshank ME; Pan J; Cotton SC; Kavanagh K; Robertson C; Cuschieri K; Cubie H; Palmer T; Pollock KG
    BJOG; 2017 Aug; 124(9):1386-1393. PubMed ID: 28102928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV knowledge, vaccine knowledge, and vaccine acceptance in women with cervical cytology anomalies attending colposcopy clinics in Puerto Rico.
    Roura-Monllor J; Nieves-Muñoz J; Ortiz AP; Romaguera J
    Int J Gynaecol Obstet; 2018 Oct; 143(1):52-58. PubMed ID: 29992564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
    Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
    J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing high quality information about human papillomavirus for women after treatment for high-grade cervical dysplasia.
    Dyson S; Pitts M; Lyons A; Mullins R
    Sex Health; 2010 Mar; 7(1):49-54. PubMed ID: 20152096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
    Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
    Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Women's Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study.
    O'Connor M; Waller J; Gallagher P; Martin CM; O'Leary JJ; D'Arcy T; Prendiville W; Flannelly G; Sharp L;
    Womens Health Issues; 2015; 25(5):528-34. PubMed ID: 26189936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
    Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
    Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland.
    Pollock KG; Kavanagh K; Potts A; Love J; Cuschieri K; Cubie H; Robertson C; Cruickshank M; Palmer TJ; Nicoll S; Donaghy M
    Br J Cancer; 2014 Oct; 111(9):1824-30. PubMed ID: 25180766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
    Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
    Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.
    Dorton BJ; Vitonis AF; Feldman S
    Hum Vaccin Immunother; 2016 Jun; 12(6):1639-45. PubMed ID: 26839185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
    Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
    Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.